MADRIGAL PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable, Related Parties
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Increase (Decrease) in Accounts Receivable, Related Parties of -$7.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2019-02-27
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2016-12-31 was $0.00.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2016-09-30 was $0.00.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2016-06-30 was $0.00.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2016-03-31 was -$7.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2016 was -$7.00K.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $0.00 derived: sum of 3 quarters · filed 2019-02-27 | -$7.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | -$7.00K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$7.00K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | -$7.00K 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |